KOE:000250

Sam Chun Dang Pharm. Co., Ltd · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 13:47 UTC

Last close

n/aKRW

Market data

751.9xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed
- Computed from the filing for 2025
3.2%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
2.3%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
-15.7%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.25Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
KRW
- computed

What it pays out is the furthest below its sector's middle: 0.09 against 0.54 on the market's range.

Follow one won

lens 1 of 9

After what it costs to make

45.6%

After running the business

3.6%

After interest and tax

2.3%

After what it must reinvest

-15.7%

Kept after the dividend

-17.7%

after what it costs to make, 45.6% of sales; after running the business, 3.6% of sales; after interest and tax, 2.3% of sales; after what it must reinvest, -15.7% of sales; kept after the dividend, -17.7% of sales

The five stops

5 of 5 read

After what it costs to make105,692,646,00045.6%
After running the business8,325,201,0003.6%
After interest and tax5,261,823,0002.3%
After what it must reinvest-36,352,583,000-15.7%
Kept after the dividend-41,004,077,000-17.7%

Of every unit of sales, -0.18 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales231,787,681,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
After what it costs to make105,692,646,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
After running the business8,325,201,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
After interest and tax5,261,823,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
After what it must reinvest-36,352,583,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW
Kept after the dividend-41,004,077,000
Source
computed
Statement
income
Fiscal year
2025
Reported in
KRW